Apotheek E. Derveaux
0412.637.109 · rovalta.com · 24/09/2026
Apotheek E. Derveaux
Overview
What does Apotheek E. Derveaux do?
Apotheek E. Derveaux is a Public limited company incorporated in 1972. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Tervuren.
3080 Tervuren · FlandreSee on map
Joint committees (1)
- 313
Trend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Gross margin | 90,9 k € | +23.7% | 73,5 k € | -9.8% | 81,5 k € | +24.8% | 65,3 k € | +52.8% | 42,7 k € | -17.4% | 51,7 k € | +23.9% | 41,8 k € | -53.2% | 89,3 k € | +54.4% | 57,9 k € | +5.3% | 54,9 k € | +8.1% | 50,8 k € | -63.4% | 138,7 k € | +78.1% | 77,9 k € | -6.7% | 83,4 k € | -7.7% | 90,4 k € | -31.1% | 131,3 k € | -1.3% | 133 k € | +136% | 56,3 k € | -0.2% | 56,4 k € |
| EBITDA | 24,1 k € | +210% | 7,8 k € | -57.0% | 18 k € | +18.6% | 15,2 k € | -41.8% | 26,1 k € | +464% | 4,6 k € | -67.7% | 14,4 k € | -71.9% | 51 k € | +15.1% | 44,4 k € | +47.7% | 30 k € | +14.2% | 26,3 k € | -77.1% | 115 k € | +112% | 54,2 k € | +11.6% | 48,5 k € | +126% | 21,5 k € | -75.2% | 86,7 k € | +35.3% | 64,1 k € | +89.2% | 33,9 k € | -25.3% | 45,4 k € |
| Operating result | 19,2 k € | +674% | 2,5 k € | -76.3% | 10,5 k € | +53.9% | 6,8 k € | -62.7% | 18,2 k € | +561% | -4 k € | -265% | 2,4 k € | -92.1% | 30,5 k € | -11.9% | 34,6 k € | +266% | 9,4 k € | +65.5% | 5,7 k € | -94.0% | 94,4 k € | +171% | 34,9 k € | +270% | 9,4 k € | +155% | -17,3 k € | -158% | 29,7 k € | +347% | 6,7 k € | +117% | -40 k € | -207% | 37,5 k € |
| Net result | 11,6 k € | +2133% | -572,3 € | -111% | 5,3 k € | +60.7% | 3,3 k € | -72.2% | 11,9 k € | +412% | -3,8 k € | -473% | 1 k € | -95.5% | 22,6 k € | -2.0% | 23 k € | +207% | 7,5 k € | +79.5% | 4,2 k € | -93.1% | 60,7 k € | +117% | 28 k € | +588% | 4,1 k € | +109% | -45,1 k € | -270% | 26,5 k € | +51.4% | 17,5 k € | +138% | -45,7 k € | -294% | 23,5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 311,2 k € | +3.9% | 299,6 k € | -0.2% | 300,2 k € | +1.8% | 294,9 k € | +1.1% | 291,6 k € | +4.3% | 279,6 k € | -1.3% | 283,5 k € | +0.4% | 282,4 k € | +8.7% | 259,9 k € | +9.7% | 236,8 k € | +3.3% | 229,3 k € | +1.9% | 225,1 k € | +36.9% | 164,4 k € | +20.5% | 136,4 k € | +3.1% | 132,4 k € | -25.4% | 177,5 k € | +17.6% | 151 k € | +13.1% | 133,5 k € | -25.5% | 179,1 k € |
| Total assets | 372,2 k € | -2.3% | 381,1 k € | +11.3% | 342,5 k € | -12.9% | 393,1 k € | +21.1% | 324,6 k € | +6.9% | 303,7 k € | -6.7% | 325,7 k € | -2.4% | 333,7 k € | +10.4% | 302,3 k € | +3.7% | 291,6 k € | -13.3% | 336,4 k € | -0.3% | 337,4 k € | +7.3% | 314,5 k € | +6.7% | 294,7 k € | -13.0% | 338,6 k € | -7.4% | 365,9 k € | -22.5% | 471,9 k € | -35.1% | 727,7 k € | +121% | 329,4 k € |
| Cash | 68,8 k € | +37.6% | 50 k € | -10.2% | 55,7 k € | -1.2% | 56,4 k € | -30.8% | 81,4 k € | +63.4% | 49,8 k € | -30.0% | 71,2 k € | +18.6% | 60 k € | -61.7% | 156,5 k € | +47.9% | 105,8 k € | +15.8% | 91,4 k € | +25.9% | 72,6 k € | -30.5% | 104,5 k € | +137% | 44,1 k € | +30.6% | 33,8 k € | -45.0% | 61,4 k € | -21.4% | 78,1 k € | +10.2% | 70,8 k € | +489% | 12 k € |
| Debts | 61 k € | -25.1% | 81,5 k € | +337% | 18,6 k € | +64.9% | 11,3 k € | +62.3% | 7 k € | -71.1% | 24,1 k € | +410% | 4,7 k € | +2.1% | 4,6 k € | -89.1% | 42,5 k € | +2.5% | 41,5 k € | -54.5% | 91,1 k € | -9.0% | 100 k € | -27.4% | 137,7 k € | -12.7% | 157,8 k € | -23.3% | 205,7 k € | +9.8% | 187,4 k € | -41.4% | 319,9 k € | -45.6% | 588,5 k € | +294% | 149,4 k € |
| Other | |||||||||||||||||||||||||||||||||||||
| Workforce | – | – | – | – | – | – | – | – | – | – | 0,6 ETP | -25.0% | 0,8 ETP | +33.3% | 0,6 ETP | -25.0% | 0,8 ETP | +167% | 0,3 ETP | -72.7% | 1,1 ETP | -8.3% | 1,2 ETP | +100% | 0,6 ETP | +50.0% | 0,4 ETP | ||||||||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 2 active · 20 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
PhilClapharma● Active | 0675.782.469 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/08/2026 | 28/06/2025 | 13/08/2024 | 20/07/2023 | 26/08/2022 | 14/07/2021 |
| General meeting | 31/07/2026 | 06/06/2025 | 07/06/2024 | 02/06/2023 | 03/06/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
21 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 31/07/2026 | 26/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 06/06/2025 | 28/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 07/06/2024 | 13/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 02/06/2023 | 20/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 03/06/2022 | 26/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 04/06/2021 | 14/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 05/06/2020 | 24/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 07/06/2019 | 29/08/2019 | Dutch | |
| Micro model | 30/06/2017 | 30/09/2017 | 31/10/2017 | Dutch | |
| Micro model | 31/12/2016 | 02/06/2017 | 19/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 03/06/2016 | 30/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 05/06/2015 | 31/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 06/06/2014 | 29/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 07/06/2013 | 13/06/2013 | Dutch | |
| Abridged modelCorrection | 31/12/2011 | 01/06/2012 | 20/08/2012 | Dutch | |
| Abridged model | 31/12/2011 | 01/06/2012 | 11/06/2012 | Dutch | |
| Abridged model | 31/12/2010 | 03/06/2011 | 11/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 04/06/2010 | 04/06/2010 | Dutch | |
| Abridged model | 31/12/2008 | 05/06/2009 | 28/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 30/06/2008 | 18/08/2008 | Dutch | |
| Abridged model | 31/12/2006 | 01/06/2007 | 22/08/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 2 active · 20 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates12/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
- Mandates01/08/2017BENAMING - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates22/07/2016ONTSLAGEN - BENOEMINGEN
- Mandates04/12/2015ONTSLAGEN - BENOEMINGEN
- Mandates08/06/2009KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates10/01/2005BENAMING - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates08/09/2004ONTSLAGEN - BENOEMINGEN
- Mandates23/07/2004ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202511,6 k €↑
- 2024Annual accounts 2024-572,3 €↓
- 2023Annual accounts 20235,3 k €↑
- 2022Annual accounts 20223,3 k €↓
- 2021Annual accounts 202111,9 k €↑
- 2020Annual accounts 2020-3,8 k €↓
- 2019Annual accounts 20191 k €↓
- 2018Annual accounts 201822,6 k €↓
- 2017Annual accounts 201723 k €↑
- 2016Annual accounts 20167,5 k €↑
- 2016Name changeApotheek E. Derveaux
- 2015Annual accounts 20154,2 k €↓
- 2014Annual accounts 201460,7 k €↑
- 2013Annual accounts 201328 k €↑
- 2012Annual accounts 20124,1 k €↑
- 2011Annual accounts 2011-45,1 k €↓
- 2010Annual accounts 201026,5 k €↑
- 2009Annual accounts 200917,5 k €↑
- 2008Annual accounts 2008-45,7 k €↓
- 2007Annual accounts 200723,5 k €
- 2007Name changeAPOTHEEK LIEVENS
- 01/09/1972IncorporationPublic limited company